Clinical trials
Phase 2 Lymphoma, B-Cell trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2013 | 1 |
| 2016 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Italiana Linfomi - ETS | 2 |
| Andrés José Maria Ferreri | 1 |
| AstraZeneca | 1 |
| Celgene | 1 |
| Debiopharm International SA | 1 |
| International Extranodal Lymphoma Study Group (IELSG) | 1 |
| Miltenyi Biomedicine GmbH | 1 |
| Novartis Pharmaceuticals | 1 |
| Regeneron Pharmaceuticals | 1 |
| Seagen Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 11 |
| Lymphoma, Follicular | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Recurrence | 2 |
| Burkitt Lymphoma | 1 |
| Hematologic Diseases | 1 |
| Lymphoma, Mantle-Cell | 1 |
| Meningeal Carcinomatosis | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.